Your browser doesn't support javascript.
loading
Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy.
Dong, Shengli; Matossian, Margarite D; Yousefi, Hassan; Khosla, Maninder; Collins-Burow, Bridgette M; Burow, Matthew E; Alahari, Suresh K.
Afiliação
  • Dong S; TYK Medicines Inc., Block D, No. 778 Huaxi Avenue, Changxing, 313100, Zhejiang, People's Republic of China. shengli.dong@tykmedicines.com.
  • Matossian MD; Department of Biochemistry and Molecular Biology, LSUHSC, CSRB 406, New Orleans, LA, 70112, USA. shengli.dong@tykmedicines.com.
  • Yousefi H; Tulane University School of Medicine, New Orleans, LA, 70118, USA.
  • Khosla M; Department of Biochemistry and Molecular Biology, LSUHSC, CSRB 406, New Orleans, LA, 70112, USA.
  • Collins-Burow BM; Department of Biochemistry and Molecular Biology, LSUHSC, CSRB 406, New Orleans, LA, 70112, USA.
  • Burow ME; Tulane University School of Medicine, New Orleans, LA, 70118, USA.
  • Alahari SK; Tulane University School of Medicine, New Orleans, LA, 70118, USA.
Sci Rep ; 13(1): 11843, 2023 07 22.
Article em En | MEDLINE | ID: mdl-37481672
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article